Skip to main content

Advertisement

SpringerLink
Log in

Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The myometrium, especially the junctional zone (JZ), is now well documented to have a role in the pathogenesis of adenomyosis. Cannabinoid receptors have been shown to participate in the establishment of endometriosis and its pain perception. However, its relation to adenomyosis has not been identified yet. The aim of this study was to investigate the expression of cannabinoid receptor type I (CB1) and type II (CB2) in myometrium of uteri with and without adenomyosis and determine the correlation between their levels and clinical parameters of adenomyosis. We collected tissue samples of JZ and the outer myometrium from 45 premenopausal women with adenomyosis and 34 women without adenomyosis. CB1 and CB2 messenger RNA (mRNA) and protein expression levels were evaluated by the use of Western blotting and real-time quantitative polymerase chain reaction from all samples. Clinical information on the severity of dysmenorrhea and other data were collected. We found both CB1 and CB2 mRNA and protein levels in women with adenomyosis were significantly higher than those of controls, and CB1 expression levels in JZ were positively correlated with the severity of dysmenorrhea. These data suggest that cannabinoid receptor CB1 may be involved in the pathogenesis of dysmenorrhea in adenomyosis and may be a potential therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Naftalin J, Hoo W, Pateman K, Mavrelos D, Holland T, Jurkovic D. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27(12):3432–3439.

    Article  CAS  PubMed  Google Scholar 

  2. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109(3):380–388.e1.

    Article  PubMed  Google Scholar 

  3. Donnez J, Donnez O, Dolmans MM. Introduction: uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018;109(3):369–370.

    Article  PubMed  Google Scholar 

  4. Habiba M, Benagiano G. Uterine adenomyosis. 1st ed. New York, NY: Springer; 2015.

    Google Scholar 

  5. Hricak H, Alpers C, Crooks LE, Sheldon PE. Magnetic resonance imaging of the female pelvis: initial experience. AJR Am J Roentgenol. 1983;141(6):1119–1128.

    Article  CAS  PubMed  Google Scholar 

  6. Brosens JJ, de Souza NM, Barker FG. Uterine junctional zone: function and disease. Lancet. 1995;346(8974):558–560.

    Article  CAS  PubMed  Google Scholar 

  7. Curtis KM, Hillis SD, Marchbanks PA, Peterson HB. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol. 2002;187(3):543–544.

    Article  PubMed  Google Scholar 

  8. Ibrahim MG, Chiantera V, Frangini S, et al. Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis. Fertil Steril. 2015;104(6):1475–1483.e3.

    Article  CAS  PubMed  Google Scholar 

  9. Kishi Y, Shimada K, Fujii T, et al. Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium. PloS One. 2017;12(12):e0189522.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Zhang Y, Zhou L, Li TC, Duan H, Yu P, Wang HY. Ultrastructural features of endometrial-myometrial interface and its alteration in adenomyosis. Int J Clin Exp Pathol. 2014;7(4):1469–1477.

    PubMed  PubMed Central  Google Scholar 

  11. Sun FQ, Duan H, Wang S, Li JJ. 17β-estradiol induces overproliferation in adenomyotic human uterine smooth muscle cells of the junctional zone through hyperactivation of the estrogen receptor-enhanced RhoA/ROCK signaling pathway. Reprod Sci. 2015;22(11):1436–1444.

    Article  CAS  PubMed  Google Scholar 

  12. WangS,DuanH,ZhangY,SunFQ. Abnormalactivationof RhoA/ROCK-I signaling in junctional zone smooth muscle cells of patients with adenomyosis. Reprod Sci. 2016;23(3):333–341.

    Article  CAS  Google Scholar 

  13. Guo SW, Mao X, Ma Q, Liu X. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril. 2013;99(1):231–240.

    Article  CAS  PubMed  Google Scholar 

  14. Fusi L, Cloke B, Brosens JJ. The uterine junctional zone. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):479–491.

    Article  PubMed  Google Scholar 

  15. Schrot RJ, Hubbard JR. Cannabinoids: medical implications. Ann Med. 2016;48(3):128–141.

    Article  CAS  PubMed  Google Scholar 

  16. Kaplan BLF. The role of CB1 in immune modulation by cannabinoids. Pharmacol Ther. 2013;137(3):365–374.

    Article  CAS  PubMed  Google Scholar 

  17. Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB2 receptor and its role as a regulator ofinflammation. Cell Mol Life Sci CMLS. 2016;73(23):4449–4470.

    Article  CAS  PubMed  Google Scholar 

  18. Servettaz A, Kavian N, Nicco C, et al. Targeting the cannabinoid pathway limits the development offibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol. 2010;177(1):187–196.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Velasco G, Sanchez C, Guzman M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436–444.

    Article  CAS  PubMed  Google Scholar 

  20. Fraguas-Sanchez AI, Martln-Sabroso C, Torres-Suarez AI. Insights into the effects of the endocannabinoid system in cancer: a review. Br J Pharmacol. 2018;175(13):2566–2580.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Maccarrone M. Endocannabinoid signaling in female reproductive events: a potential therapeutic target? Expert Opin Ther Targets. 2015;19(11):1423–1427.

    Article  CAS  PubMed  Google Scholar 

  22. Miller MR, Mannowetz N, Iavarone AT, et al. Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone. Science. 2016;352(6285):555–559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sanchez AM, Quattrone F, Pannese M, et al. The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis. Hum Reprod. 2017;32(1):175–184.

    CAS  PubMed  Google Scholar 

  24. Dmitrieva N, Nagabukuro H, Resuehr D, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151(3):703–710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Leconte M, Nicco C, Ngo C, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol. 2010;177(6):2963–2970.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rocha ALL, Reis FM, Petraglia F. New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs. 2012;21(7):905–919.

    Article  CAS  PubMed  Google Scholar 

  27. Sanchez AM, Cioffi R, Vigano P, et al. Elevated systemic levels of endocannabinoids and related mediators across the menstrual cycle in women with endometriosis. Reprod Sci. 2016;23(8):1071–1079.

    Article  CAS  PubMed  Google Scholar 

  28. McAllister S, Sinharoy P. The influence ofchronic WIN 55, 2122 treatment on vaginal hyperalgesia, VEGF, and NGF in a rat model of endometriosis. J Pain. 2018;19(3):S78.

    Article  Google Scholar 

  29. Zhang Y, Yu P, Sun F, Li TC, Cheng JM, Duan H. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 2015;94(4):412–418.

    Article  CAS  PubMed  Google Scholar 

  30. McCarthy S, Tauber C, Gore J. Femalepelvicanatomy:MR assessment of variations during the menstrual cycle and with use of oral contraceptives. Radiology. 1986;160(1):119–123.

    Article  CAS  PubMed  Google Scholar 

  31. Wiczyk HP, Janus CL, Richards CJ, et al. Comparison of magnetic resonance imaging and ultrasound in evaluating follicular and endometrial development throughout the normal cycle. Fertil Steril. 1988;49(6):969–972.

    Article  CAS  PubMed  Google Scholar 

  32. Brown HK, Stoll BS, Nicosia SV, et al. Uterine junctional zone: correlation between histologic findings and MR imaging. Radiology. 1991;179(2):409–413.

    Article  CAS  PubMed  Google Scholar 

  33. Exacoustos C, Luciano D, Corbett B, et al. The uterine junctional zone: a 3-dimensional ultrasound study of patients with endometriosis. Am J Obstet Gynecol. 2013;209(3):248.e1–248.e7.

    Article  Google Scholar 

  34. Hald K, Lieng M. Assessment ofperiodic blood loss: interindividual and intraindividual variations of pictorial blood loss assessment chart registrations. J Minim Invasive Gynecol. 2014;21(4):662–668.

    Article  PubMed  Google Scholar 

  35. Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrelreleasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198(4):373.e1–e7.

    Article  CAS  Google Scholar 

  36. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009;79(3):189–193.

    Article  CAS  PubMed  Google Scholar 

  37. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101–1108.

    Article  CAS  PubMed  Google Scholar 

  38. Maccarrone M, Bab I, Biro T, et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015;36(5):277–296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Lu HC, Mackie K. An introduction to the endogenous cannabinoid system. Biol Psychiatry. 2016;79(7):516–525.

    Article  CAS  PubMed  Google Scholar 

  40. De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab. 2009;23(1):1–15.

    Article  PubMed  CAS  Google Scholar 

  41. Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligandreceptor signaling in the mouse uterus. Proc Natl Acad Sci U S A. 1995;92(10):4332–4336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Taylor AH, Abbas MS, Habiba MA, Konje JC. Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle. Histochem Cell Biol. 2010;133(5):557–565.

    Article  CAS  PubMed  Google Scholar 

  43. Resuehr D, Glore DR, Taylor HS, Bruner-Tran KL, Osteen KG. Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Fertil Steril. 2012;98(4): 948–956.e1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Pagano E, Orlando P, Finizio S, et al. Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle. Biochem Pharmacol. 2017;124:83–93.

    Article  CAS  PubMed  Google Scholar 

  45. Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ. Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol. 2004;190(1):2–9.

    Article  CAS  PubMed  Google Scholar 

  46. Brosens J, Barker F. Adenomyosis: time for a reappraisal. Lancet. 1993;341(8838):181–182.

    Article  CAS  PubMed  Google Scholar 

  47. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.

    Article  CAS  PubMed  Google Scholar 

  48. Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185.

    Article  PubMed  Google Scholar 

  49. Garcia-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109(3):371–379.

    Article  PubMed  Google Scholar 

  50. Gentilini D, Besana A, Vigano P, et al. Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1/2 pathways. Fertil Steril. 2010;93(8):2588–2593.

    Article  CAS  PubMed  Google Scholar 

  51. Han H, Liang X, Wang J, et al. Cannabinoid receptor 1 contributes to sprouted innervation in endometrial ectopic growth through mitogen-activated protein kinase activation. Brain Res. 2017;1663:132–140.

    Article  CAS  PubMed  Google Scholar 

  52. McHugh D, Page J, Dunn E, Bradshaw HB. Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol. 2012;165(8):2414–2424.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Bilgic E, Meydanli EG, Kose S, et al. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis. Acta Histochem. 2017;119(5):523–532.

    Article  CAS  PubMed  Google Scholar 

  54. MacCarrone M, De Felici M, Bari M, Klinger F, Siracusa G, Finazzi-Agro A. Down-regulation of anandamide hydrolase in mouse uterus by sex hormones. Eur J Biochem. 2000;267(10):2991–2997.

    Article  CAS  PubMed  Google Scholar 

  55. Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA. 1997;94(8):4188–4192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ribeiro ML, Vercelli CA, Sordelli MS, et al. 17beta-oestradiol and progesterone regulate anandamide synthesis in the rat uterus. Reprod Biomed Online. 2009;18(2):209–218.

    Article  CAS  PubMed  Google Scholar 

  57. Scorticati C, Fernandez-Solari J, De Laurentiis A, et al. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc Natl Acad Sci USA. 2004;101(32):11891–11896.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Maia J, Almada M, Silva A, et al. The endocannabinoid system expression in the female reproductive tract is modulated by estrogen. J Steroid Biochem Mol Biol. 2017;174:40–47.

    Article  CAS  PubMed  Google Scholar 

  59. El-Talatini MR, Taylor AH, Konje JC. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil Steril. 2010;93(6):1989–1996.

    Article  CAS  PubMed  Google Scholar 

  60. Mehasseb MK, Bell SC, Pringle JH, Habiba MA. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril. 2010;93(7):2130–2136.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Prof. Dongmei Tian and Prof. Hui Chen for their help in English editing and statistical analysis, respectively.

Author information

Authors and Affiliations

  1. Department of Minimally Invasive Gynecologic Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, No. 17 Qi Helou Road, Dong Cheng District, Beijing, 100006, People’s Republic of China

    Xue Shen (MD), Hua Duan (MD, PhD), Sha Wang (MD, PhD), Yu-Yan Wang (MD) & Si-Li Lin (MD)

  2. Department of Obstetrics and Gynecology, Beijing Luhe Hospital, Capital Medical University, Beijing, People’s Republic of China

    Wei Hong (MD)

Authors
  1. Xue Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hua Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sha Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Si-Li Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hua Duan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, X., Duan, H., Wang, S. et al. Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis. Reprod. Sci. 26, 1618–1625 (2019). https://doi.org/10.1177/1933719119833483

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719119833483

Keywords

Search

Navigation